Short description
MyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders.
Description
MyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. It is a venture-supported biotechnology company focused on developing novel therapeutics for the treatment of muscle disorders. Its lead product opportunity utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness.
Total funding
$$121212
Sign in for full access
Location
Union City, California, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
1-10
Founders
John Kincaid, Mark De Souza, Michael G. Kelly